R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Weekly News Round-up – 1/4/21

4 months ago By Charlotte Di Salvo
  • Share on

  • Facebook
  • Linkedin

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech and Pfizer. 

GSK SUPPORTS NOVAVAX COVID 19 VACCINE MANUFACTURING – In collaboration with NOVAVAX and the UK’s Vaccines Task Force, GSK has agreed to support the manufacturing of up to 60 million COVID-19 vaccines. The recent partnership could increase production capacity and meet the April 15 deadline to offer a first dose to all over 50’s. 

AMGEN TO ACQUIRE RODEO THERAPEUTICS – Under a new agreement, Amgen Inc. will acquire Rodeo Therapeutics Corporation. The strategic move by Amgen seeks to collaborate with Rodeo’s enzyme programme (15-PGDH) to develop ‘first-in-class’ therapeutics alongside Amgen’s inflammation research. Any outstanding shares of Rodeo will be acquired by Amgen in exchange for an upfront payment of $55 million. 

2021 VACCINE TARGET BOOSTED BY BIONTECH-PFIZER – With further manufacturing capacity, expansion BioNTech and Pfizer could deliver 2.5 billion COVID-19 doses by 2022. The recent addition of BioNTech’s latest facility in Marburg, Germany, has resulted in expansion of the manufacturing and supply network to accelerate commercial production. 

R&D
IBM unveils next steps in AI technology with quantum computer

Clinical
First cell-based gene therapy approved for Adult Multiple Myeloma by FDA

Manufacturing 
Human error costs J&J 15 million COVID-19 vaccines

That’s all for now. See you next week!

Charlotte Di Salvo, Junior Medical Writer
Proventa International

More news

DeepMind’s AI Predicts Structures for More Than 350,000 Proteins

In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...

7 days ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

DeepMind’s AI Predicts Structures for More Than 350,000 Proteins

In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...

7 days ago

Rapid COVID Antibody Test Can Reveal Immune Status in 15 Minutes

As of July 2021, the number of hospitalisations and deaths due to COVID-19 have significantly dropped since the second peak around January this year. In addition to restrictions, the greatest contributor to this drop has been the rapid vaccine uptake...

1 week ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Rapid COVID Antibody Test Can Reveal Immune Status in 15 Minutes

As of July 2021, the number of hospitalisations and deaths due to COVID-19 have significantly dropped since the second peak around January this year. In addition to restrictions, the greatest contributor to this drop has been the rapid vaccine uptake...

1 week ago

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...

2 weeks ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...

2 weeks ago
Working With us

Interested?
Reserve your space